Holen Sie sich die Stockscreener-App
67.11
1.01%
0.67
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$66.44
Offen:
$66.61
24-Stunden-Volumen:
2.80M
Relative Volume:
0.90
Marktkapitalisierung:
$30.29B
Einnahmen:
$5.08B
Nettoeinkommen (Verlust:
$142.33M
KGV:
203.36
EPS:
0.33
Netto-Cashflow:
$797.33M
1W Leistung:
+2.95%
1M Leistung:
+7.46%
6M Leistung:
+14.99%
1J Leistung:
+25.04%
1-Tages-Spanne:
$66.39
$67.17
1-Wochen-Bereich:
$64.80
$67.17
52-Wochen-Spanne:
$53.05
$71.36
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Vergleichen Sie VTR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
67.11 | 29.43B | 5.08B | 142.33M | 797.33M | 0.33 |
|
WELL
Welltower Inc
|
161.09 | 102.48B | 8.41B | 1.08B | 2.39B | 1.74 |
|
DOC
Healthpeak Properties Inc
|
18.99 | 12.66B | 2.80B | 279.29M | 1.20B | 0.40 |
|
OHI
Omega Healthcare Investors Inc
|
38.63 | 11.00B | 1.08B | 448.00M | 779.91M | 1.61 |
|
AHR
American Healthcare Reit Inc
|
37.89 | 5.92B | 2.07B | -37.81M | 84.15M | -0.27 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Allianz Asset Management GmbH Has $49.70 Million Stock Position in Ventas, Inc. (NYSE:VTR) - MarketBeat
6,840 Shares in Ventas, Inc. (NYSE:VTR) Purchased by Kingsview Wealth Management LLC - MarketBeat
Is Ventas Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com
Ventas, Inc. (NYSE:VTR) CFO Sells $271,451.52 in Stock - MarketBeat
Ventas, Inc. (NYSE:VTR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Ventas, Inc. Q2 2025 Earnings Preview: Strong Performance ExpectedNews and Statistics - IndexBox
Ventas, Inc. (NYSE:VTR) is B&I Capital AG's 10th Largest Position - MarketBeat
Wealth Alliance LLC Invests $282,000 in Ventas, Inc. (NYSE:VTR) - MarketBeat
What drives Ventas Inc. stock priceFree Technical Analysis Support - jammulinksnews.com
Ventas, Inc. (NYSE:VTR) CEO Debra A. Cafaro Sells 4,375 Shares - MarketBeat
What analysts say about Ventas Inc. stockBreakout portfolio performance - jammulinksnews.com
Ventas' Q2 2025 Earnings: Is This Healthcare REIT a Buy for Long-Term Income Investors? - AInvest
Ventas Earnings Preview: Analysts Expect 6.3% YoY Increase in FFO - AInvest
Ventas Earnings Preview: What to Expect - Yahoo Finance
Cerity Partners LLC Purchases 13,871 Shares of Ventas, Inc. (NYSE:VTR) - MarketBeat
Edgestream Partners L.P. Has $1.78 Million Stake in Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas Inc. Stock Analysis and ForecastRapid profit acceleration - Autocar Professional
Insider Selling at Ventas, Inc. (VTR): Governance Risks and Investor Sentiment in a High-Performance REIT - AInvest
How Much Would It Take to Earn $100 a Month From Ventas Stock in 2025? - AInvest
How Much Would It Take To Earn $100 A Month From Ventas Stock - Yahoo Finance
New York State Common Retirement Fund Grows Stock Holdings in Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas, Inc. (NYSE:VTR) CFO Sells $11,001,264.48 in Stock - MarketBeat
Debra A. Cafaro Sells 14,753 Shares of Ventas, Inc. (NYSE:VTR) Stock - MarketBeat
Insider Selling: Ventas, Inc. (NYSE:VTR) CEO Sells 1,224 Shares of Stock - MarketBeat
Los Angeles Capital Management LLC Buys 945,150 Shares of Ventas, Inc. (NYSE:VTR) - MarketBeat
Envestnet Asset Management Inc. Has $21.49 Million Holdings in Ventas, Inc. (NYSE:VTR) - MarketBeat
Bridgewater Advisors Inc. Buys Shares of 5,736 Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas, Inc. (NYSE:VTR) Shares Purchased by Cwm LLC - MarketBeat
Ventas, Inc. (NYSE:VTR) CEO Sells $19,169.80 in Stock - MarketBeat
JPMorgan Upgrades Ventas (VTR) to “Overweight” with $72 Price Target - MSN
(VTR) Investment Analysis - news.stocktradersdaily.com
Ventas EVP Probst sells $271k in shares after option exercise By Investing.com - Investing.com South Africa
Ventas EVP Probst sells $271k in shares after option exercise - Investing.com
Barclays da un voto de confianza a Puig tras su récord de ventas: potencial de más del 30% - Yahoo Finanzas
Massachusetts Financial Services Co. MA Has $379.34 Million Stock Holdings in Ventas, Inc. (NYSE:VTR) - MarketBeat
Kathmere Capital Management LLC Acquires New Position in Ventas, Inc. (NYSE:VTR) - MarketBeat
News | Chicago healthcare REIT buys senior living facility near Seattle - CoStar
Ventas (VTR) Could Be a Great Choice - Yahoo Finance
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):